ID: MRFR/HC/4385-HCR | February 2021 | Region: Global | 90 pages
Market Scenario
Global Immunoassay Market is expected to register a healthy CAGR over the forecast period. The immunoassay market size accounted for USD 18,626.7 million in 2018 and is projected to register a CAGR of 5.9% during the forecast period. Immunoassay is a bioanalytical method to detect or measure specific proteins or other substances through their properties as antigens or antibodies. Immunoassays use antigen-antibody reaction to detect the concentration of a wide range of biological substances in the blood and other fluids. Some of the prominent market drivers are the rising worldwide prevalence of chronic and infectious diseases, increasing adoption of immunoassay-based point-of-care (POC) testing and rapid testing, flourishing biotechnology and pharmaceutical sector, and technological advancements in immunoassay instruments and the introduction of novel automated systems. For instance, according to the American Chemical Society (ACS), in the US, clinical laboratories perform more than 7 billion tests on blood, urine, and other samples from patients every year, which is supporting the market growth.
On the flip side, lack of reimbursement policies and rigorous regulatory requirements for the approval of immunoassay instruments and consumables from respective authorities are anticipated to restrict the market growth during the forecast period.
Major Key Players
Some of the Major leading players in the global immunoassay market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.p.A.
Intended Audience
Market Segmentation
The global immunoassay market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into reagents and kits, analyzers/instruments, software, and services. The reagents and kits segment was the largest value contributor in the global immunoassay market in 2018 due to the rising incidence of chronic and infectious diseases, growing use of reagents and kits along with its repetitive purchase by the users.
On the basis of technology, the market has been divided into radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), enzyme-linked fluorescent assay (ELFA), chemiluminescence immunoassay (CLIA), rapid test, and others.
By indication, the global immunoassay market has been categorized into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune diseases, and others.
Based on end user, the market has been classified into hospitals, clinical laboratories, blood banks, pharmaceutical and biotechnology companies, academic and research institutes, and others.
The global immunoassay market has been segmented on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The immunoassay market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European immunoassay market has been segmented into Western Europe and Eastern Europe. The Western Europe immunoassay market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The immunoassay market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The immunoassay market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas held substantial market share in 2018 attributed to the availability of government funds, presence of key market players, surging number of research projects in laboratories coupled with increasing adoption of immunoassay in clinical diagnostics in the US and Canada. Companies such as Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, and Quidel Corporation are headquartered in the US, thereby enabling early market initiation along with prompt product supply and service delivery.
Global Immunoassay Market Share (%), by Region, 2018
Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis
Europe would be the second-largest value contributor in the global immunoassay market size throughout the forecast period attributed to growing adoption in diagnostic measures, rising use of chemiluminescent immunoassay, and a prospering growth in the pharmaceutical and biotechnology companies in the UK, Germany, and France. As per data published by the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2016, Europe accounted for 21.5% of world pharmaceutical sales that was increased to 22.2% of global pharmaceutical sales in 2017.
Asia-Pacific is expected to represent significant market growth during next seven years owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness about immunoassay tests, growth in healthcare spending in emerging countries, namely, India, China, and Australia. The number of the elderly population in the Asia-Pacific region is rising at an unprecedented rate. The statistics presented by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) stated that in 2016, about 12.4% of the Asia-Pacific population was 60 years or older, which is projected to increase to more than a quarter (1.3 billion individuals) by the end of 2050.
The immunoassay market in the Middle East & Africa would witness the modest market growth rate from 2019 to 2025. The Middle East would spearhead the market attributed to growth in healthcare sector along with developing healthcare infrastructure in the Gulf Cooperation Council (GCC) countries such as Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman.
Global Immunoassay Market, by Product
Global Immunoassay Market, by Technology
Global Immunoassay Market, by Indication
Global Immunoassay Market, by End User
Global Immunoassay Market, by Region
The report for Global Immunoassay Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Report Attribute/Metric | Details |
---|---|
Market Size | USD 18,626.7 Million (2025) |
CAGR | 5.9% (2019-2025) |
Base Year | 2019 |
Forecast Period | 2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Indication, End User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.P.A. |
Key Market Opportunities | Increasing Adoption of immunoassay-based point-of-care (POC) testing and rapid testing |
Key Market Drivers | The Rising prevalence of chronic and infectious diseases |
Frequently Asked Questions (FAQ) :
Immunoassay Market was valued at over USD 18.6 billion in 2018.
Immunoassay Market is expected to exhibit a strong 5.9% CAGR over the forecast period from 2019 to 2025.
Immunoassays are used to detect the concentration of a wide range of biological substances in blood.
The rising prevalence of chronic and infectious diseases is the major driver for the global immunoassay market.
Lack of support from reimbursement agencies and strict regulatory requirements are the major restraint on the global immunoassay market.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions and Limitations
2.4 Market Structure
Chapter 3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Detection Technique Trends & Assessment
Chapter 5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6 Global Immunoassay Market, by Product
6.1 Introduction
6.2 Reagents and Kits
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Analyzers/Instruments
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Software and Services
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7 Global Immunoassay Market, by Technology
7.1 Introduction
7.2 Radioimmunoassay (RIA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Enzyme-linked Immunosorbent Assay (ELISA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Enzyme-linked Fluorescent Assay (ELFA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5 Chemiluminescence Immunoassay (CLIA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.6 Rapid Test
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.7 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8 Global Immunoassay Market, by Indication
8.1 Introduction
8.2 Therapeutic Drug Monitoring
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Oncology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Cardiology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.5 Endocrinology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.6 Infectious Diseases
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.7 Autoimmune Diseases
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.8 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9 Global Immunoassay Market, by End User
9.1 Introduction
9.2 Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3 Clinical Laboratories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4 Blood Banks
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.5 Pharmaceutical and Biotechnology Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.6 Academic and Research Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.7 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 10 Global Immunoassay Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Developments & Strategies
Chapter 12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financial Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 F. Hoffmann-La Roche Ltd
12.3 Siemens Healthineers
12.4 bioMérieux SA
12.5 Becton, Dickinson and Company
12.6 Danaher Corporation
12.7 Abbott Laboratories
12.8 Merck KGaA
12.9 Sysmex Corporation
12.10 Ortho Clinical Diagnostics/Carlyle Group
12.11 Quidel Corporation
12.12 DiaSorin S.p.A.
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Immunoassay Industry
Chapter 14 Appendix
LIST OF TABLES
Table 1 Global Immunoassay Market Synopsis, 2020-2027
Table 2 Global Immunoassay Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Immunoassay Market, by Region, 2020-2027 (USD Million)
Table 4 Global Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 5 Global Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 6 Global Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 7 Global Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 8 North America: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 9 North America: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 10 North America Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 11 North America Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 12 US: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 13 US: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 14 US Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 15 US Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 16 Canada: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 17 Canada: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 18 Canada Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 19 Canada Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 20 Latin America: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 21 Latin America: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 22 Latin America Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 23 Latin America Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 24 Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 25 Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 26 Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 27 Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 28 Western Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 29 Western Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 30 Western Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 31 Western Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 32 Eastern Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 33 Eastern Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 34 Eastern Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 35 Eastern Europe Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 36 Asia-Pacific: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 37 Asia-Pacific: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 38 Asia-Pacific Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 39 Asia-Pacific Immunoassay Market, by End User, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Immunoassay Market, by Product, 2020-2027 (USD Million)
Table 41 Middle East & Africa: Immunoassay Market, by Technology, 2020-2027 (USD Million)
Table 42 Middle East & Africa Immunoassay Market, by Indication, 2020-2027 (USD Million)
Table 43 Middle East & Africa Immunoassay Market, by End User, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Immunoassay Market
Figure 3 Segmentation Market Dynamics for Global Immunoassay Market
Figure 4 Global Immunoassay Market Share, by Product, 2020
Figure 5 Global Immunoassay Market Share, by Technology, 2020
Figure 6 Global Immunoassay Market Share, by Indication, 2020
Figure 7 Global Immunoassay Market Share, by End User, 2020
Figure 8 Global Immunoassay Market Share, by Region, 2020
Figure 9 North America: Immunoassay Market Share, by Country, 2020
Figure 10 Europe: Immunoassay Market Share, by Country, 2020
Figure 11 Asia-Pacific: Immunoassay Market Share, by Country, 2020
Figure 12 Middle East & Africa: Immunoassay Market Share, by Country, 2020
Figure 13 Global Immunoassay Market: Company Share Analysis, 2020 (%)
Figure 14 Thermo Fisher Scientific Inc.: Key Financials
Figure 15 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 16 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 17 F. Hoffmann-La Roche Ltd: Key Financials
Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 20 Siemens Healthineers: Key Financials
Figure 21 Siemens Healthineers: Segmental Revenue
Figure 22 Siemens Healthineers: Geographical Revenue
Figure 23 bioMérieux SA: Key Financials
Figure 24 bioMérieux SA: Segmental Revenue
Figure 25 bioMérieux SA: Geographical Revenue
Figure 26 Becton, Dickinson and Company: Key Financials
Figure 27 Becton, Dickinson and Company: Segmental Revenue
Figure 28 Becton, Dickinson and Company: Geographical Revenue
Figure 29 Danaher Corporation: Key Financials
Figure 30 Danaher Corporation: Segmental Revenue
Figure 31 Danaher Corporation: Geographical Revenue
Figure 32 Abbott Laboratories: Key Financials
Figure 33 Abbott Laboratories: Segmental Revenue
Figure 34 Abbott Laboratories: Geographical Revenue
Figure 35 Merck KGaA: Key Financials
Figure 36 Merck KGaA: Segmental Revenue
Figure 37 Merck KGaA: Geographical Revenue
Figure 38 Sysmex Corporation: Key Financials
Figure 39 Sysmex Corporation: Segmental Revenue
Figure 40 Sysmex Corporation: Geographical Revenue
Figure 41 Ortho Clinical Diagnostics/Carlyle Group: Key Financials
Figure 42 Ortho Clinical Diagnostics/Carlyle Group: Segmental Revenue
Figure 43 Ortho Clinical Diagnostics/Carlyle Group: Geographical Revenue
Figure 44 Quidel Corporation: Key Financials
Figure 45 Quidel Corporation: Segmental Revenue
Figure 46 Quidel Corporation: Geographical Revenue
Figure 47 DiaSorin S.p.A.: Key Financials
Figure 48 DiaSorin S.p.A.: Segmental Revenue
Figure 49 DiaSorin S.p.A.: Geographical Revenue
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.